Turoctocog alfa pegol (N8-GP) in severe hemophilia A: Long-term safety and efficacy in previously treated patients of all ages in the pathfinder8 study.

Lentz, Steven R; Kavakli, Kaan; Klamroth, Robert; Misgav, Mudi; Nagao, Azusa; Tosetto, Alberto; Jørgensen, Pernille Juul; Zak, Marek; Nemes, Laszlo

Lentz, Steven R; Kavakli, Kaan; Klamroth, Robert; Misgav, Mudi; Nagao, Azusa; Tosetto, Alberto; Jørgensen, Pernille Juul; Zak, Marek; Nemes, Laszlo.

Afiliación

Lentz SR; Division of Hematology, Oncology, and Blood & Marrow Transplantation Department of Internal Medicine University of Iowa Carver College of Medicine Iowa City Iowa USA.
Kavakli K; Department of Haematology Ege University Faculty of Medicine Children's Hospital Bornova Izmir Turkey.
Klamroth R; Department for Internal Medicine Vascular Medicine and Haemostaseology Vivantes Klinikum im Friedrichshain Berlin Germany.
Misgav M; National Hemophilia Center Sheba Medical Center Tel Hashomer Israel.
Nagao A; Department of Blood Coagulation Ogikubo Hospital Tokyo Japan.
Tosetto A; Hemophilia and Thrombosis Center Hematology Department San Bortolo Hospital Vicenza Italy.
Jørgensen PJ; Biostatistics Biopharm Novo Nordisk A/S Bagsværd Denmark.
Zak M; Medical and Science Biopharm Novo Nordisk A/S Bagsværd Denmark.
Nemes L; National Hemophilia Center and Hemostasis Department Medical Center of the Hungarian Defence Forces Budapest Hungary.